The third Covid-19 vaccine registered in Russia is based on a “perfectly conventional” platform, and those who have been injected experienced no side effects, the head of the Chumakov Scientific Center, which created it, told RT.
The CoviVac vaccine received national approval in Russia on February 20. The first batch of doses is expected to be available to the public in mid-March, according to the government.
Continue reading https://on.rt.com/b2xs